Evidence map›Paper›PMID 32530138›Full record

ArticleThoracic cancer2020

Role of radiotherapy in the management of malignant airway obstruction.

Hoon Sik Choi, Bae Kwon Jeong, Hojin Jeong, In Bong Ha, Ki Mun Kang

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hoon Sik ChoiRadiation Oncology, Gyeongsang National University School of Medicine, and Gyeongsang National University Changwon Hospital, Changwon-si, South Korea.ORCID 0000-0003-0998-0685
Bae Kwon JeongRadiation Oncology, Gyeongsang National University School of Medicine, and Gyeongsang National University Hospital, Jinju-si, South Korea.ORCID 0000-0001-8015-6061
Hojin JeongRadiation Oncology, Gyeongsang National University School of Medicine, and Gyeongsang National University Hospital, Jinju-si, South Korea.
In Bong HaRadiation Oncology, Gyeongsang National University School of Medicine, and Gyeongsang National University Hospital, Jinju-si, South Korea.
Ki Mun KangRadiation Oncology, Gyeongsang National University School of Medicine, and Gyeongsang National University Changwon Hospital, Changwon-si, South Korea.
Gyeongsang National University · KRChangwon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA significant proportion of lung cancer patients suffer from malignant airway obstruction (MAO). Palliative external beam radiotherapy (EBRT) is often used to control the symptoms caused by MAO. In this study, we report the effect of palliative EBRT on lung cancer with MAO and analyze the factors that influence it.

methodsThis study included 75 patients with MAO in lung cancer who underwent palliative EBRT, between 2009 and 2018 and were analyzed retrospectively. Change of dyspnea, tumor response, and overall survival (OS) were recorded. Univariate and multivariate analyses were performed to determine the prognostic factors for treatment outcomes.

resultsThe median follow-up duration was 2.5 months, and median OS was 2.3 months. Out of 75 patients, dyspnea was improved in 46 patients (61.3%), and tumor was partially decreased in 39 patients (52%). Symptoms improved in all tumor responding patients. The symptom improvement was significantly affected by radiation dose and time to EBRT. The tumor response was significantly affected by pathology, radiation dose, and time to EBRT.

conclusionsPalliative EBRT is an effective and safe treatment option for patients with MAO in lung cancer. In particular, high-dose irradiation and prompt treatment can improve treatment results. KEY POINTS: SIGNIFICANT FINDINGS OF THE STUDY: In MAO patients, tumor response is an important factor for resolving dyspnea and improving survival rate. In order to increase the tumor response, high-dose irradiation and prompt treatment after symptoms occur are necessary. WHAT THIS STUDY ADDS: Our study reported the effects of EBRT and prognostic factors in MAO patients. We emphasize that palliative EBRT is a relatively safe and effective treatment in MAO patients, which is a complement to previous studies.

Indexed as

AgedAged, 80 and overAirway ObstructionFemaleHumansLung NeoplasmsMaleMiddle AgedRadiotherapy DosageTreatment OutcomeLung neoplasmmalignant airway obstructionpalliativeradiotherapy

Identifiers

PMID32530138
PMCPMC7396370
OpenAlexW3034535344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.